Navigation Links
Vanda Pharmaceuticals Reports First Quarter 2012 Results
Date:5/8/2012

ion for the first quarter of 2011.Total operating expenses for the first quarter of 2012 were $16.5 million, compared to $7.5 million for the first quarter of 2011.  The primary driver of the higher expenses in the first quarter of 2012 was the ongoing support of the tasimelteon Non-24 and MDD clinical studies. 

Vanda recorded a net loss of $8.0 million for the first quarter of 2012, compared to net income of $0.1 million for the first quarter of 2011.  Diluted net loss per share for the first quarter of 2012 was $0.28, compared to diluted net income of $0.00 per share for the first quarter of 2011. First Quarter 2012 Key Financial Figures(1)Three Months EndedMarch 31December 31(in thousands, except per share amounts)20122011  Change ($)Change (%)Total revenues

$
8,141$
8,370$
(229)(3%)Research & development  expenses

12,18010,5561,62415%General & administrative expenses

3,9093,34556417%Non-cash stock-based compensation(2)

1,4021,318846%Loss before tax benefit

(7,962)(5,809)(2,153)(37%)Tax benefit

-(286)286100%Net loss

(7,962)(5,523)(2,439)(44%)Diluted net loss per share

$
(0.28)$
(0.20)$
(0.08)(40%)Select Cash Flow Data(1)  

Three Months EndedMarch 31March 31(in thousands)20122011Net cash provided by (used in)Operating activities

$
(8,690)$
(3,264)Investing activities

28,86113,225Financing activities

--Select Balance Sheet Data(1) March 31December 31March 31(in thousands)201220112011Total cash and marketable securities

$
57,250$
7,896$
94,555(1) Unaudited(2) Non-cash stock-based compensation is allocated to both Research & development and General & administrative expenses OPERATIONAL HIGHLIGHTSOn January 26, 2012, Vanda announced that initial clinical data in the RESET study revealed the potential of tasimelteon to reset the body clock in Non-
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
4. Vanda Presents Phase III Iloperidone Efficacy Data
5. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
6. Vanda Pharmaceuticals Provides Update on Iloperidone
7. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
8. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
10. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
11. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014  Zacks.com announces the list ... Zacks Equity Research analysts discuss the latest news and events ... the blog include the Biogen (Nasdaq: BIIB - Free Report ... Biotechnology (NYSE: PBYI - Free Report ), AbbVie (NYSE: ... CELG - Free Report ). Today, Zacks is ...
(Date:7/31/2014)... , July 31, 2014 Vermillion, Inc. (NASDAQ: ... women,s health, will hold a conference call on Thursday, August ... for the second quarter ended June 30, 2014. Financial results ... call. Vermillion,s Chairman, President and CEO James ... and answer period. Date: Thursday, August 14, 2014 ...
(Date:7/31/2014)... 31, 2014 TB Alliance, a not-for-profit ... faster and affordable treatments, announced the appointment of ... External Affairs. Mr. Brock comes to TB Alliance ... Donor Relations for WWF International (formerly known as ... Brock will guide the TB Alliance,s resource development, ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 2TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2
... , , , BOSTON, Sept. ... financial gift to the Harvard Stem Cell Institute (HSCI) Seminar Series ... Terms of the gift were not disclosed. , , ... stem cell science community in which pioneers in the national and ...
... , SAN DIEGO, Sept. 1 ... in adult stem cell research and manufacturing, announced today that it ... & Drug Branch to manufacture stem cells for human clinical trials. ... law and the applicable provisions of the Code of Federal Regulations. ...
Cached Medicine Technology:Stemgent Announces Sponsorship of Harvard Stem Cell Institute Seminar Series; 2Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells 2
(Date:7/31/2014)... recently used birth control pills containing high-dose estrogen and ... breast cancer, whereas women using some other formulations did ... , a journal of the American Association for Cancer ... oral contraceptives [birth control pills] in the past year ... to never or former oral contraceptive use, and that ...
(Date:7/31/2014)... July 31, 2014 Developer Jamestown, L.P., ... on its Ponce City Market project in Atlanta’s Old ... Roebuck & Company building into best-in-class office, housing, and ... reviewed Jamestown’s experience with their construction webcam service to ... Jamestown wanted a construction camera for monitoring ...
(Date:7/31/2014)... July 31, 2014 Leelanau Peninsula’s newest winery, ... 3, 2014 at 7788 East Horn Road in Lake Leelanau. ... Trail , Aurora Cellars is the 25th winery along the ... the popular wine tour events, making its trail event debut ... 2014. , Owners David and Faye Mathia opened the ...
(Date:7/31/2014)... In today’s world, a good night’s sleep has become especially ... (a medical problem where the airway collapses during sleep and ... rest they need to face their daily challenges. , ... people in the United States alone have sleep apnea. Of ... those treated, many cannot tolerate their prescribed medical device known ...
(Date:7/31/2014)... Ce-Classes.com has announced that they are now offering ... Systematic Review of Sexual Satisfaction . The ... Journal of Clinical and Health Psychology. , This CE ... to have accurate information about sexual satisfaction so that ... The material provides a systematic review of 197 research ...
Breaking Medicine News(10 mins):Health News:Recent use of some birth control pills may increase breast cancer risk 2Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 2Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 3Health News:Aurora Cellars Joins the Leelanau Peninsula Wine Trail 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Company Provides New Course on Sexual Satisfaction 2Health News:Company Provides New Course on Sexual Satisfaction 3
... (May 14, 2012) - A team of international scientists has ... duct cancer, a deadly type of liver cancer. By identifying ... are paving the way for better understanding of how bile ... Nature Genetics . Bile Duct Cancer, or Cholangiocarcinoma, is ...
... S.C. - Clemson University researcher Julia Frugoli has received ... four-year grant from the National Science Foundation to continue ... with each other to control their growth and development. ... Clemson University,s College of Agriculture, Forestry & Life Sciences, ...
... , MONDAY, May 14 (HealthDay News) -- Feeding tubes ... according to a new study. The finding challenges the ... bed sores or helps promote their healing in this group ... The researchers did not look at how feeding tubes ...
... May 14, 2012 Persistent Systems (BSE & ... (OPD) services, and the Translational Genomics Research Institute (TGen) ... management system called Bio4D. Initial versions of the ... and genomic research, have been used at TGen in ...
... Storrs HealthDay Reporter , MONDAY, May 14 (HealthDay ... or running while toting a bottle, a pacifier or a ... nationwide survey, researchers estimated that more than 45,000 visits to ... 3 years old were because of injuries related to using ...
... News) -- Doing more repetitions with less weight builds ... with heavy weights, a new Canadian study indicates. ... to the point of fatigue, according to the researchers ... how different combinations of weight loads and repetitions affected ...
Cached Medicine News:Health News:Scientists make breakthrough in bile duct cancer with discovery of new gene mutations 2Health News:Scientists make breakthrough in bile duct cancer with discovery of new gene mutations 3Health News:Clemson professor awarded nearly $600,000 4-year grant to study language of plants 2Health News:For Dementia Patients, Feeding Tubes May Increase Bed Sores 2Health News:New biospecimens management system in development 2Health News:Baby Bottles, Pacifiers, Sippy Cups Can Injure 2Health News:Baby Bottles, Pacifiers, Sippy Cups Can Injure 3Health News:With Weights, You Can Lighten Your Load 2
... Durable ergonomic chairs with concave seats and ... options like seats, backrests, armrests, and casters ... for top performance in a variety of ... static control, health care and office. • ...
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With Tubular Base....
Medicine Products: